1. CMU Intellectual Repository

Browsing by Author Cecilia Kanyama

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
26-Feb-2015C-Reactive Protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settingsMark W. Tenforde; Nikhil Gupte; David W. Dowdy; David M. Asmuth; Ashwin Balagopal; Richard B. Pollard; Patcharaphan Sugandhavesa; Javier R. Lama; Sandy Pillay; Sandra W. Cardoso; Jyoti Pawar; Breno Santos; Cynthia Riviere; Noluthando Mwelase; Cecilia Kanyama; Johnstone Kumwenda; James G. Hakim; Nagalingeswaran Kumarasamy; Robert Bollinger; Richard D. Semba; Thomas B. Campbell; Amita Gupta
1-Jul-2020Distal sensory peripheral neuropathy in human immunodeficiency virus type 1-positive individuals before and after antiretroviral therapy initiation in diverse resource-limited settingsAlyssa C. Vecchio; Christina M. Marra; Jeffrey Schouten; Hongyu Jiang; Johnstone Kumwenda; Khuanchai Supparatpinyo; James Hakim; Ned Sacktor; Thomas B. Campbell; Srikanth Tripathy; Nagalingeswaran Kumarasamy; Alberto La Rosa; Breno Santos; Marcus T. Silva; Cecilia Kanyama; Cindy Firnhaber; Mina C. Hosseinipour; Rosie Mngqibisa; Colin Hall; Paola Cinque; Kevin Robertson
1-Jan-2018Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trialRupak Shivakoti; Erin R. Ewald; Nikhil Gupte; Wei Teng Yang; Cecilia Kanyama; Sandra W. Cardoso; Breno Santos; Khuanchai Supparatpinyo; Sharlaa Badal-Faesen; Javier R. Lama; Umesh Lalloo; Fatima Zulu; Jyoti S. Pawar; Cynthia Riviere; Nagalingeswaran Kumarasamy; James Hakim; Richard Pollard; Barbara Detrick; Ashwin Balagopal; David M. Asmuth; Richard D. Semba; Thomas B. Campbell; Jonathan Golub; Amita Gupta
1-May-2019Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased neurological dysfunctionKevin R. Robertson; Bibilola Oladeji; Hongyu Jiang; Johnstone Kumwenda; Khuanchai Supparatpinyo; Thomas B. Campbell; James Hakim; Srikanth Tripathy; Mina C. Hosseinipour; Christina M. Marra; Nagalingeswaran Kumarasamy; Scott Evans; Alyssa Vecchio; Alberto La Rosa; Breno Santos; Marcus T. Silva; Sylvia Montano; Cecilia Kanyama; Cindy Firnhaber; Richard Price; Cheryl Marcus; Baida Berzins; Reena Masih; Umesh Lalloo; Ian Sanne; Sarah Yosief; Ann Walawander; Aspara Nair; Ned Sacktor; Colin Hall
1-May-2019Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited SettingsKevin R. Robertson; Hongyu Jiang; Johnstone Kumwenda; Khuanchai Supparatpinyo; Christina M. Marra; Baiba Berzins; James Hakim; Ned Sacktor; Thomas B. Campbell; Jeffrey Schouten; Katie Mollan; Srikanth Tripathy; Nagalingeswaran Kumarasamy; Alberto La Rosa; Breno Santos; Marcus T. Silva; Cecilia Kanyama; Cindy Firhnhaber; Robert Murphy; Colin Hall; Cheryl Marcus; Linda Naini; Reena Masih; Mina C. Hosseinipour; Rosie Mngqibisa; Sharlaa Badal-Faesen; Sarah Yosief; Alyssa Vecchio; Apsara Nair
1-Oct-2011A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settingsKevin Robertson; Johnstone Kumwenda; Khuanchai Supparatpinyo; Jeanne H. Jiang; Scott Evans; Thomas B. Campbell; Richard W. Price; Robert Murphy; Colin Hall; Christina M. Marra; Cheryl Marcus; Baiba Berzins; Reena Masih; Breno Santos; Marcus T. Silva; N. Kumarasamy; Ann Walawander; Apsara Nair; Srkanth Tripathy; Cecilia Kanyama; Mina Hosseinipour; Silvia Montano; Alberto La Rosa; Farida Amod; Ian Sanne; Cindy Firnhaber; James Hakim; Pim Brouwers
14-Mar-2019One month of rifapentine plus isoniazid to prevent HIV-related TuberculosisSusan Swindells; Ritesh Ramchandani; Amita Gupta; Constance A. Benson; Jorge Leon-Cruz; Noluthando Mwelase; Marc A. Jean Juste; Javier R. Lama; Javier Valencia; Ayotunde Omoz-Oarhe; Khuanchai Supparatpinyo; Gaerolwe Masheto; Lerato Mohapi; Rodrigo O. Da Silva Escada; Sajeeda Mawlana; Peter Banda; Patrice Severe; James Hakim; Cecilia Kanyama; Deborah Langat; Laura Moran; Janet Andersen; Courtney V. Fletcher; Eric Nuermberger; Richard E. Chaisson
1-Oct-2015Pre-cART elevation of CRP and CD4<sup>+</sup>t-cell immune activation associated with HIV clinical progression in a multinational case-cohort studyAshwin Balagopal; David M. Asmuth; Wei Teng Yang; Thomas B. Campbell; Nikhil Gupte; Laura Smeaton; Cecilia Kanyama; Beatriz Grinsztejn; Breno Santos; Khuanchai Supparatpinyo; Sharlaa Badal-Faesen; Javier R. Lama; Umesh G. Lalloo; Fatima Zulu; Jyoti S. Pawar; Cynthia Riviere; Nagalingeswaran Kumarasamy; James Hakim; Xiao Dong Li; Richard B. Pollard; Richard D. Semba; David L. Thomas; Robert C. Bollinger; Amita Gupta
1-Sep-2019Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn; Michael D. Hughes; Justin Ritz; Robert Salata; Peter Mugyenyi; Evelyn Hogg; Linda Wieclaw; Robert Gross; Catherine Godfrey; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Faesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Anchalee Avihingsanon; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; B. Grinsztejn; P. N. Mugyenyi; A. Collier; R. Salata; C. Godfrey; E. Hogg; M. Hughes; J. Ritz; L. Wieclaw; T. Sise; J. W. Mellors; C. Wallis; C. V. Fletcher; M. Gandhi; R. Gross; R. T. Schooley; R. Walensky; M. van Schalkwyk; S. Faesen; R. Mngqibisa; J. Valencia; E. Montalban; N. Kumarasamy; C. Kanyama; S. W. Cardoso; B. R. Santos; B. Mansfield; H. Mugerwa; B. W. Ndege; R. Secours; W. Samaneka; D. Kadam; V. Mave; M. Makanga; S. N. Fontain; P. Sugandhavesa; A. Avihingsanon; L. Nakibuuka; H. Nassolo; P. Anthony; V. Kulkarni; M. Nsubuga; J. van Wyk; J. Rooney; Y. van Delft; R. Leavitt; R. Luk; A. Benns; L. Hovind; A. Shahkolahi
1-Jun-2022Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trialAnchalee Avihingsanon; Michael D. Hughes; Robert Salata; Catherine Godfrey; Caitlyn McCarthy; Peter Mugyenyi; Evelyn Hogg; Robert Gross; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Badal-aesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije Van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Cornelius Munyanga; Maganizo Chagomerana; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; Beatriz Grinsztejn
Showing results 1 to 10 of 10